Advertisement
Screener

BioCorRx Inc. (BICX) Income (Loss) from Continuing Operations before Income Taxes, Domestic

1.6 / 5 stars · 26/82 Roast Me

BioCorRx Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic

BioCorRx Inc. (BICX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$923.55 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Income Statement

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2023-08-14

  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-06-30 was -$923.55K.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-03-31 was -$1.01M.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-09-30 was -$951.01K.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-06-30 was -$1.32M.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$5.21M.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$3.51M.
  • BioCorRx Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was -$6.05M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2023-06-30-$923.55K
10-Q · filed 2023-08-14
-$1.93M
10-Q · filed 2023-08-14
2023-03-31-$1.01M
10-Q · filed 2023-05-15
2022-09-30-$951.01K
10-Q · filed 2022-11-14
-$2.27M
derived: sum of 2 quarters · filed 2023-08-14
-$3.21M
10-Q · filed 2022-11-14
-$4.42M
derived: sum of 4 quarters · filed 2023-08-14
2022-06-30-$1.32M
10-Q · filed 2023-08-14
-$2.26M
10-Q · filed 2023-08-14
-$3.46M
derived: sum of 3 quarters · filed 2023-08-14
-$4.83M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$944.99K
10-Q · filed 2023-05-15
-$2.15M
derived: sum of 2 quarters · filed 2023-05-15
-$3.51M
derived: sum of 3 quarters · filed 2023-05-15
-$4.57M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$2.56M
derived: sum of 2 quarters · filed 2022-11-14
-$3.63M
derived: sum of 3 quarters · filed 2022-11-14
-$5.21M
10-K · filed 2022-03-31
2021-09-30-$1.36M
10-Q · filed 2022-11-14
-$2.43M
derived: sum of 2 quarters · filed 2022-11-14
-$4.01M
10-Q · filed 2022-11-14
-$4.91M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$1.06M
10-Q · filed 2022-08-15
-$2.65M
10-Q · filed 2022-08-15
-$3.55M
derived: sum of 3 quarters · filed 2022-08-15
-$4.34M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$1.58M
10-Q · filed 2022-05-16
-$2.49M
derived: sum of 2 quarters · filed 2022-05-16
-$3.27M
derived: sum of 3 quarters · filed 2022-05-16
-$4.01M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$904.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$1.69M
derived: sum of 2 quarters · filed 2022-03-31
-$2.43M
derived: sum of 3 quarters · filed 2022-03-31
-$3.51M
10-K · filed 2022-03-31
2020-09-30-$785.17K
10-Q · filed 2021-11-15
-$1.52M
derived: sum of 2 quarters · filed 2021-11-15
-$2.60M
10-Q · filed 2021-11-15
-$3.80M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$738.48K
10-Q · filed 2021-08-13
-$1.82M
10-Q · filed 2021-08-13
-$3.02M
derived: sum of 3 quarters · filed 2021-08-13
-$4.05M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$1.08M
10-Q · filed 2021-05-17
-$2.28M
derived: sum of 2 quarters · filed 2021-05-17
-$3.32M
derived: sum of 3 quarters · filed 2021-05-17
-$5.36M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$2.24M
derived: sum of 2 quarters · filed 2021-03-31
-$4.28M
derived: sum of 3 quarters · filed 2021-03-31
-$6.05M
10-K · filed 2021-03-31
2019-09-30-$1.03M
10-Q · filed 2020-11-16
-$3.07M
derived: sum of 2 quarters · filed 2020-11-16
-$4.85M
10-Q · filed 2020-11-16
2019-06-30-$2.04M
10-Q · filed 2020-08-14
-$3.81M
10-Q · filed 2020-08-14